These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 1561480
1. [A review of clinical studies on the efficacy and tolerance of intravenous ciprofloxacin]. Memoli M. Recenti Prog Med; 1992 Jan; 83(1):27-34. PubMed ID: 1561480 [Abstract] [Full Text] [Related]
2. Ciprofloxacin: an update on clinical experience. Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R. Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063 [Abstract] [Full Text] [Related]
3. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ. Am J Med; 1987 Apr 27; 82(4A):295-300. PubMed ID: 3555051 [Abstract] [Full Text] [Related]
4. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections. Fass RJ. Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037 [Abstract] [Full Text] [Related]
5. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. Louie TJ. CMAJ; 1994 Mar 01; 150(5):669-76. PubMed ID: 8313286 [Abstract] [Full Text] [Related]
6. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan. Kobayashi H. Am J Med; 1987 Apr 27; 82(4A):169-73. PubMed ID: 3555031 [Abstract] [Full Text] [Related]
7. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ. Arch Intern Med; 1989 Oct 27; 149(10):2269-73. PubMed ID: 2508586 [Abstract] [Full Text] [Related]
9. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease. Galante D, Esposito S, Barba D, Giusti G. Chemioterapia; 1986 Oct 27; 5(5):322-6. PubMed ID: 3791479 [Abstract] [Full Text] [Related]
13. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections. Lorian V, Pavletich K. Drugs Exp Clin Res; 1994 Oct 27; 20(5):209-14. PubMed ID: 7875058 [Abstract] [Full Text] [Related]
17. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections. Frankenschmidt A, Naber KG, Bischoff W, Kullmann K. J Urol; 1997 Oct 27; 158(4):1494-9. PubMed ID: 9302150 [Abstract] [Full Text] [Related]